Autopsy report · NCT05867901
A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk GISTs in NED State Based on MRD Detection Via Liquid Biopsy
Cause of deathOther
“Enrollment has been temporarily paused pending ethics review and implementation of the revised study protocol. Follow-up of previously enrolled participants is continuing.”
Life of this trial
- Registered 1 month before it started.
- Suspended: paused, and may or may not restart.
- 66 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Sponsor
- Peking University People's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Gastrointestinal Stromal Tumors
- Interventions
- Tumor-Informed ctDNA-Based MRD Testing; Contrast-Enhanced CT
- Participants
- 66 (planned, not actual)
- Sites
- 1
- Countries
- China
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.